FLEXION THERAPEUTICS, INC. Q2 2021
Commercial Metrics
Overview
August 4, 2021
Commercial Overview: Q2 Performance Metrics
Net Sales - Current vs Same Qtr | |||
$30.0 | Prior Year | $28.2 | |
$25.0 | |||
$20.0 | $15.5 | 82% | |
$15.0 | |||
$10.0 | |||
$5.0 | |||
$- | |||
Q2 2020 | Q2 2021 | ||
Dollars in millions |
Net Sales - Current vs Prior Qtr | Demand - Current vs Same Qtr Prior | Demand - Current vs Prior Qtr | |||||
$30.0 | $28.2 | 60,000 | Year | 56,798 | 60,000 | 53,089 | 56,798 |
$24.6 | |||||||
$25.0 | 15% | 50,000 | 50,000 | ||||
36,697 | |||||||
$20.0 | 40,000 | 55% | 40,000 | 7% | |||
$15.0 | 30,000 | 30,000 | |||||
$10.0 | 20,000 | 20,000 | |||||
$5.0 | 10,000 | 10,000 | |||||
$- | - | Q2 2020 | Q2 2021 | - | Q1 2021 | Q2 2021 | |
Q1 2021 | Q2 2021 | ||||||
Dollars in millions | Zilretta Units | Zilretta Units |
•
•
•
ZILRETTA® net sales of $28.2 million in Q2 2021 In Q2 2,105 accounts purchased ZILRETTA
Of the 2,105 accounts that purchased in Q2, 90% had purchased in a prior quarter
Flexion primarily sells ZILRETTA to specialty distributors; Flexion recognizes ZILRETTA sales upon receipt of product by distributors; demand volume refers to end-user account purchases (physicians, clinics, and certain medical centers or hospitals) who purchase from these specialty distributors
2
ZILRETTA Net Sales by Quarter
ZILRETTA Net Sales ($ Millions)
$28.2
$26.3 | ||||||
$24.6 | ||||||
$23.7 | ||||||
$15.5
Q2 2020 | Q3 2020 | Q4 2020 | Q1 2021 | Q2 2021 |
Flexion recognizes ZILRETTA sales upon receipt of product by specialty distributors.
3
ZILRETTA Demand by Quarter
ZILRETTA Units
50,056
46,617
36,697
56,798
53,089
Q2 2020 | Q3 2020 | Q4 2020 | Q1 2021 | Q2 2021 |
Flexion primarily sells ZILRETTA to specialty distributors; Flexion recognizes ZILRETTA sales upon receipt of product by distributors; demand refers to end-user account purchases (physicians, clinics, and certain medical centers or hospitals) who purchase from these specialty distributors.
4
In Q2, ~42% of Demand Came from Accounts Purchasing More than 100 Units
ZILRETTA Units(Accounts)
60,000
50,000
40,000
30,000
20,000
10,000
-
Accts that purchased 301+ units
Accts that purchased 101-300 units Accts that purchased 1-100 units
Accounts | |
46,617 | 1,979 |
3,600 | 8 |
12,023 | 76 |
30,994 1,895
Accounts | |||||||||
Accounts | 56,798 | 2,105 | |||||||
Accounts | 53,089 | ||||||||
2,044 | |||||||||
50,056 | 2,002 | 7,784 | 17 | ||||||
6,631 | 15 | ||||||||
5,748 | 13 | ||||||||
13,992 | 13,588 | 84 | 15,804 | 97 | |||||
85 | |||||||||
30,316 | 1,904 | 32,870 | 1,945 | 33,210 | 1,991 |
Q3 2020 | Q4 2020 | Q1 2021 | Q2 2021 |
Flexion primarily sells ZILRETTA to specialty distributors; Flexion recognizes ZILRETTA sales upon receipt of product by distributors; demand refers to end-user account purchases (physicians, clinics, and certain medical centers or hospitals) who purchase from these specialty distributors.
5
Attachments
- Original document
- Permalink
Disclaimer
Flexion Therapeutics Inc. published this content on 04 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 August 2021 22:45:07 UTC.
